Factors Influencing Pain Expression in Patients with Cancer: An Expert Opinion.
Abuse
Alcoholism
Cancer pain
Opioids
Pain expression
Personal global impression
Psychological factor
Journal
Pain and therapy
ISSN: 2193-8237
Titre abrégé: Pain Ther
Pays: New Zealand
ID NLM: 101634491
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
11
03
2021
accepted:
07
05
2021
pubmed:
21
5
2021
medline:
21
5
2021
entrez:
20
5
2021
Statut:
ppublish
Résumé
Pain is a multidimensional experience that requires an appropriate assessment, and simple numbering may not be enough for the different components that are involved in the clinical expression. In consideration of the subjectivity of the symptom, each assessment should start from the way in which the patients perceive the pain and from how they deal with it. Some factors related to individual patient characteristics may make pain management difficult because of interference with the clinical pain expression. These factors may amplify the reporting of pain. Cognitive disorders and psychological distress seem to strongly influence pain expression and may render the analgesic treatment more difficult. Aberrant behaviors, such as alcoholism, smoking, and opioid misuse, may play a role, although geographic differences were found in terms of prevalence of the phenomenon, especially in some countries. Finally, the assessment of patients' expectation and the meaning of the personal feeling of changes in pain intensity provide new concepts in pain assessment, which may allow better personalization of the analgesic therapy. A modern pain assessment should include a multitude of factors influencing the phenotype of pain.
Identifiants
pubmed: 34014529
doi: 10.1007/s40122-021-00272-x
pii: 10.1007/s40122-021-00272-x
pmc: PMC8586270
doi:
Types de publication
Journal Article
Langues
eng
Pagination
765-775Informations de copyright
© 2021. The Author(s).
Références
Bennett MI, Eisenberg E, Ahmedzai SH, et al. Standards for the management of cancer-related pain across Europe—a position paper from the EFIC Task Force on cancer pain. Eur J Pain. 2019;23:660–8.
pubmed: 30480345
pmcid: 7027571
doi: 10.1002/ejp.1346
Mercadante S. The patient with difficult cancer pain. Cancers (Basel). 2019;11(4):E565.
doi: 10.3390/cancers11040565
Portenoy RK, Ahmed E. Cancer pain syndromes. Hematol Oncol Clin North Am. 2018;32:371–86.
pubmed: 29729775
doi: 10.1016/j.hoc.2018.01.002
de la Cruz M, Fan J, Yennu S, et al. The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. Support Care Cancer. 2015;23:2427–33.
pubmed: 25617070
doi: 10.1007/s00520-015-2610-3
Mercadante S, Masedu F, Balzani I, et al. Prevalence of delirium in advanced cancer patients in home care and hospice and outcomes after one week of palliative care. Support Care Cancer. 2018;26:913–9.
pubmed: 28980071
doi: 10.1007/s00520-017-3910-6
Mercadante S, Adile C, Ferrera P, Cortegiani A, Casuccio A. Delirium assessed by memorial delirium assessment scale in advanced cancer patients admitted to an acute palliative/supportive care unit. Curr Med Res Opin. 2017;33:1303–8.
pubmed: 28375046
doi: 10.1080/03007995.2017.1315332
Delgado-Guay MO, Yennurajalingam S, Bruera E. Delirium with severe symptom expression related to hypercalcemia in a patient with advanced cancer: an interdisciplinary approach to treatment. J Pain Symptom Manag. 2008;36:442–9.
doi: 10.1016/j.jpainsymman.2007.11.004
Mercadante S, Adile C, Ferrera P, Cortegiani A, Casuccio A. Symptom expression in advanced cancer patients admitted to an acute supportive/palliative care unit with and without delirium. Oncologist. 2019;24(6):e358–64.
pubmed: 30355776
doi: 10.1634/theoncologist.2018-0244
Delgado-Guay M, Parsons HA, Li Z, et al. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer. 2009;17:573–9.
pubmed: 19005686
doi: 10.1007/s00520-008-0529-7
Tien AY, Schlaepfer TE, Fisch HU. Self-reported somatization symptoms associated with risk for extreme alcohol use. Arch Fam Med. 1998;1:33–7.
doi: 10.1001/archfami.7.1.33
Kim YJ, Dev R, Reddy A, et al. Association between tobacco use, symptom expression, and alcohol and illicit drug use in advanced cancer patients. J Pain Symptom Manag. 2016;51:762–8.
doi: 10.1016/j.jpainsymman.2015.11.012
Parson HA, Delgado-Guay MO, El Osta B, et al. Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med. 2008;11:964–8.
doi: 10.1089/jpm.2008.0037
Kwon JH, Tanco K, Hui D, Reddy A, Bruera E. Chemical coping versus pseudoaddiction in patients with cancer pain. Palliat Support Care. 2014;12:413–7.
pubmed: 24524251
doi: 10.1017/S1478951513001351
Kwon JH, Tanco K, Park JC, et al. Frequency, predictors, and medical record documentation of chemical coping among advanced cancer patients. Oncologist. 2015;20:692–7.
pubmed: 25933929
pmcid: 4571788
doi: 10.1634/theoncologist.2015-0012
Dalal S, Hui D, Nguyen L, et al. Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer. 2012;118:3869–77.
pubmed: 22180337
doi: 10.1002/cncr.26694
Hui D, Park M, Shamieh O, et al. Personalized symptom goals and response in patients with advanced cancer. Cancer. 2016;122:1774–81.
pubmed: 26970366
doi: 10.1002/cncr.29970
Arthur J, Tanco K, Park M, et al. Personalized pain goal as an outcome measure in routine cancer pain assessment. J Pain Symptom Manag. 2018;56:80–7.
doi: 10.1016/j.jpainsymman.2018.03.004
Mercadante S, Adile C, Aielli F, et al. Personalized pain goals and responses in advanced cancer patients. Pain Med. 2020;21:e215–21.
pubmed: 31633792
Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain. 2003;4:2–21.
pubmed: 14622723
doi: 10.1054/jpai.2003.1
Farrar JT, Portenoy RK, Berlin J, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000;88:287–94.
pubmed: 11068116
doi: 10.1016/S0304-3959(00)00339-0
Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61:277–84.
pubmed: 7659438
doi: 10.1016/0304-3959(94)00178-H
Wang X, Cleeland C, Mendoza T, et al. The effects of pain severity on health-related quality of life. Cancer. 1999;86:1845–55.
doi: 10.1002/(SICI)1097-0142(19991101)86:9<1848::AID-CNCR29>3.0.CO;2-M
Hui D, Bruera E. The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manag. 2017;53:630–43.
doi: 10.1016/j.jpainsymman.2016.10.370
Bruera E, Bush SH, Willey J, et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer. 2009;115:2004–12.
pubmed: 19241420
doi: 10.1002/cncr.24215
de la Cruz M, Yennu S, Liu D, Wu J, Reddy A, Bruera E. Increased symptom expression among patients with delirium admitted to an acute palliative care unit. J Palliat Med. 2017;20:638–41.
pubmed: 28157431
pmcid: 5915265
doi: 10.1089/jpm.2016.0315
Mercadante S, Masedu F, Maltoni M, et al. Symptom expression in advanced cancer patients admitted to hospice or home care with and without delirium. Intern Emerg Med. 2019;14:515–20.
pubmed: 30334235
doi: 10.1007/s11739-018-1969-9
Mercadante S, Porzio G, Valle A, Aielli F, Casuccio A. Palliative sedation in patients with advanced cancer followed at home: a prospective study. J Pain Symptom Manag. 2014;47:860–6.
doi: 10.1016/j.jpainsymman.2013.06.019
Mercadante S, Valle A, Porzio G, et al. How do cancer patients receiving palliative care at home die? A descriptive study. J Pain Symptom Manag. 2011;42:702–9.
doi: 10.1016/j.jpainsymman.2011.01.014
Radbruch L, Nauck F, Ostgathe C, et al. What are the problems in palliative care? Results from a representative survey. Support Care. 2003;11:442–5.
doi: 10.1007/s00520-003-0472-6
Vignaroli E, Pace E, Willey J, et al. The Edmonton symptom assessment as a screening tool for depression and anxiety. J Palliat Med. 2006;9:296–303.
pubmed: 16629559
doi: 10.1089/jpm.2006.9.296
Lloyd-Williams M, Shiels C, Taylor F, Dennis M. Depression—an independent predictor of early death in patients with advanced cancer. J Affect Disord. 2009;113:127–32.
pubmed: 18558439
doi: 10.1016/j.jad.2008.04.002
Arthur J, Yennurajalingam S, Nguyen L, et al. The routine use of the Edmonton Classification System for Cancer Pain in an outpatient supportive care center. Palliat Support Care. 2015;13:1185–92.
pubmed: 25311930
doi: 10.1017/S1478951514001205
Mercadante S, Adile C, Ferrera P, Cortegiani A, Casuccio A. Symptom hyper-expression in advanced cancer patients with anxiety and depression admitted to an acute supportive/palliative care unit. Support Care Cancer. 2019;27:3081–8.
pubmed: 30607679
doi: 10.1007/s00520-018-4624-0
Modonesi C, Scarpi E, Maltoni M, et al. Impact of palliative care unit admission on symptom control evaluated by the Edmonton Symptom Assessment System. J Pain Symptom Manag. 2005;30:367–73.
doi: 10.1016/j.jpainsymman.2005.04.007
Lo C, Zimmermann C, Rydall A, et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol. 2010;28:3084–9.
pubmed: 20479397
doi: 10.1200/JCO.2009.26.9712
Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin invest Med. 2007;1:33–41.
doi: 10.25011/cim.v30i1.447
Mercadante S, Porzio G, Caruselli A, et al. The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program. J Pain Symptom Manag. 2015;49:254–7.
doi: 10.1016/j.jpainsymman.2014.06.005
Mercadante S, Adile C, Ferrera P, Casuccio A. Association between alcoholism and symptom expression, patient symptom goals, and clinical response in advanced cancer patients. Support Care Cancer. 2020;28:3361–9.
pubmed: 31760520
doi: 10.1007/s00520-019-05152-x
Mercadante S, Adile C, Ferrera P, Casuccio A. The effects of alcoholism and smoking on advanced cancer patients admitted to an acute supportive/palliative care unit. Support Care Cancer. 2017;25:2147–53.
pubmed: 28210861
doi: 10.1007/s00520-017-3620-0
Giusti R, Mazzotta M, Verna L, et al. The incidence of alcoholism in patients with advanced cancer receiving active treatment in two tertiary care centers in Italy. Alcohol Alcohol. 2019;54:47–50.
pubmed: 30260381
doi: 10.1093/alcalc/agy070
Bruera E, Moyano J, Seifert L, et al. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manag. 1995;10:599–603.
doi: 10.1016/0885-3924(95)00084-4
Passik SD, Kirsh KL, McDonald MV, et al. A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manag. 2000;19:274–86.
doi: 10.1016/S0885-3924(00)00119-6
Mercadante S. Potential strategies to combat the opioid crisis. Expert Opin Drug Saf. 2019;18:211–21.
pubmed: 30722706
doi: 10.1080/14740338.2019.1579796
Kwon JH, Hui D, Bruera E. A pilot study to define chemical coping in cancer patients using the Delphi method. J Palliat Med. 2015;18:703–6.
pubmed: 25922879
pmcid: 4522949
doi: 10.1089/jpm.2014.0446
Arthur JA, Edwards T, Lu Z, et al. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic. Cancer. 2016;122:3732–9.
pubmed: 27509305
doi: 10.1002/cncr.30240
Arthur J, Bruera E. Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer. Nat Rev Clin Oncol. 2019;16:213–26.
pubmed: 30514978
doi: 10.1038/s41571-018-0143-7
Arthur GA. Urine drug testing in cancer pain management. Oncologist. 2020;25:99–104.
pubmed: 32043770
doi: 10.1634/theoncologist.2019-0525
Arthur J, Edwards T, Reddy S, et al. Outcomes of a specialized interdisciplinary approach for patients with cancer with aberrant opioid-related behavior. Oncologist. 2018;23:263–70.
pubmed: 29021378
doi: 10.1634/theoncologist.2017-0248
Yennurajalingam S, Kang JH, Hui D, et al. Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain. J Pain Symptom Manag. 2012;44:340–50.
doi: 10.1016/j.jpainsymman.2011.09.014
Koyyalagunta D, Bruera E, Aigner C, Nusrat H, Driver L, Novy D. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med. 2013;14:667–75.
pubmed: 23631401
doi: 10.1111/pme.12100
Carmichael AN, Morgan L, Del Fabbro E. Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review. Subst Abuse Rehabil. 2016;7:71–9.
pubmed: 27330340
pmcid: 4898427
Lauridsen HH, Hartvigsen J, Manniche C, et al. Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients. BMC Musculoskelet Disord. 2006;7:82.
pubmed: 17064410
pmcid: 1635558
doi: 10.1186/1471-2474-7-82
Hui D, Bruera E. Minimal clinically important differences in the Edmonton Symptom Assessment System: the anchor is key. J Pain Symptom Manag. 2013;45:e4e5.
doi: 10.1016/j.jpainsymman.2012.12.003
Apolone G, Corli O, Caraceni A, et al. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer. 2009;100:1566–7.
pubmed: 19401688
pmcid: 2696765
doi: 10.1038/sj.bjc.6605053
Fainsinger R, Fairchild A, Nekolaichuk C, Lawlor P, Lowe S, Hanson J. Is pain intensity a predictor of the complexity of cancer pain management? J Clin Oncol. 2009;7:585–90.
doi: 10.1200/JCO.2008.17.1660
Knudsen AK, Brunelli C, Klepstad P, et al. Which domains should be included in a cancer pain classification system? Pain. 2012;153:696–703.
pubmed: 22264677
doi: 10.1016/j.pain.2011.12.005
Mercadante S, Porzio G, Adile C, et al. Pain intensity as prognostic factor in cancer pain management. Pain Pract. 2015;15:E1-8.
pubmed: 25387823
doi: 10.1111/papr.12259
Mercadante S, Gebbia V, David F, et al. Does pain intensity predict a poor opioid response in cancer patients? Eur J Cancer. 2011;47:713–7.
pubmed: 21256734
doi: 10.1016/j.ejca.2010.12.020
Mercadante S, Gebbia V, David F, et al. Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain. 2009;10:594–600.
pubmed: 19231297
doi: 10.1016/j.jpain.2008.12.002
Mercadante S, Adile C, Caruselli A, et al. The palliative-supportive care unit in a comprehensive cancer center as crossroad for patients’ oncological pathway. PLoS ONE. 2016;11(6):e0157300.
pubmed: 27332884
pmcid: 4917085
doi: 10.1371/journal.pone.0157300
Hwang S, Chang V, Fairclough D, Kasimis B. Development of a cancer pain prognostic scale. J Pain Symptom Manag. 2002;24:366–78.
doi: 10.1016/S0885-3924(02)00488-8
Kang JH, Kwon JH, Hui D, Yennurajalingam S, Bruera E. Changes in symptom intensity among cancer patients receiving outpatient palliative care. J Pain Symptom Manag. 2013;46:652–60.
doi: 10.1016/j.jpainsymman.2012.11.009
Stromgren A, Groenvold M, Petersen M, et al. Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized palliative care. J Pain Symptom Manag. 2004;27:104–13.
doi: 10.1016/j.jpainsymman.2003.06.011